NTRK2 and Ewing sarcoma: In Ewing sarcoma (ES), another type of pediatric solid tumor with possible origin in embryonal neural crest cells [81], treating human ES cells with TrkA or TrkB selective inhibitors reduced cell proliferation, and the effects were optimized when the two inhibitors were combined.